SGX Market Updates

26 SGX Primary Listed Stocks Conducted Buybacks in March 2021


PUBLISHED ON |

06 April 2021

  • In March 2021, 26 SGX primary-listed stocks bought back 58 million shares for a total consideration of S$71.8 million. This was up from 17 stocks conducting buybacks in February 2021 for a total consideration of S$49.7 million, and significantly less than the 65 stocks filing S$501.5 million amid the considerable market volatility in March 2020.

  • For 1Q21, there were 37 SGX primary-listed stocks that conducted buybacks over the quarter, with consideration totaling S$134 million. Over the quarter, the Straits Times Index (STI) gained 11.3%, and the buyback consideration represented 0.01 per cent of the S$943.8 billion in market capitalisation of all stocks listed on SGX as of 31 March.

  • Wilmar International led the 1Q21 consideration tally, buying back 8,141,700 shares in the quarter at an average price of S$5.29. As of March 31, the leading agribusiness group had purchased 0.83 per cent of its issued shares (excluding treasury shares) on the current mandate.




Total share buyback consideration for month of March 2021 totaled S$71.8 million, up from S$49.7 million in February (click here for more details), which in turn had also increased from from $12.4 million for January 2021 (click here for more details). The March 2021 buyback consideration was much lower year-on-year, with S$501.5 million in consideration reported for March 2020 amidst broad marklet volatility (click here for more details).

During March 2021, the Straits Times Index (“STI”) gained 7.3%, moving to 3,165.34 from 2,949.04 at the end of February. This brought the STI’s 1Q21 price gain to 11.3%, with dividends boosting the total return to 11.8%. This was the STI's strongest first quarter of a calendar year since 2012, and among 18 of the biggest regional and global benchmarks, the STI was the second best performer, closely following the Taiwan Stock Exchange Weighted Index as discussed here.

The combined AUM of the SPDR® Straits Times Index ETF and the Nikko AM Singapore STI ETF ended March at S$2.28 billion compared to S$2.19 billion at the end of February 2021, and compared to S$1.11 billion at the end of March 2020, with the unit creations and redemptions generating S$691 million of net inflows into the two ETFs over the last 12 months.



SGX Share Buyback Consideration March 2021



There were 26 primary-listed stocks that bought back shares in March. Like in February and January, of the stocks conducting buybacks in March, Global Investments has bought back the largest percentage of its issued shares on the current mandate. Global Investments’ current buyback mandate has seen it purchase 4.71% of its issued shares (excluding treasury shares) as of 31 March, with the preceding share buyback mandate seeing Global Investments buy back 8.52% of its issued shares (excluding treasury shares).

Wilmar International led the 1Q21 buyback consideration tally, buying back 8,141,700 shares in the quarter at an average price of S$5.29 as discussed here. As of March 31, the leading agribusiness group had purchased 0.83 per cent of its issued shares (excluding treasury shares) on the current mandate. As Wilmar International noted in its FY20 (ended Dec 31) Annual Report, during the 2020 year the company re-purchased 44.7 million of its ordinary shares for a consideration of S$190 million, at an average price of S$4.25 per share. The company also lodged the second highest buyback consideration for Singapore's primary listed stocks in the 2020 year, after DBS Group Holdings.

The table below summarises the buyback considerations in March 2021. The table is sorted by the value of the total consideration amount for the month, which combines the amount of shares or units purchased and the purchasing price of the transactions.


SGX Primary Listed Stocks
that Conducted Buybacks in March 2021
Number of
Shares/units Authorised
for Purchase in
Current Mandate
Total Number of
Shares/units Purchased
in March 2021
Total Buyback
Consideration (including
stamp duties, clearing
changes etc.)
paid or payable
for the shares
Average
Price
Paid
S$
Cumulative Number of
Shares/units purchased
in Mandate to date
Percent of
Outstanding Shares
(Excl. Treasury) purchased
in Mandate to date
OVERSEA-CHINESE BANKING CORPORATION 220,250,626 3,000,000 $35,133,870 $11.711 3,000,000 0.068
WILMAR INTERNATIONAL 635,459,880 2,426,700 $12,856,325 $5.298 52,858,100 0.830
SIIC ENVIRONMENT HOLDINGS 260,281,772 11,524,000 $4,534,927 $0.394 23,303,000 0.895
SINGAPORE EXCHANGE 107,164,240 427,400 $4,245,705 $9.934 544,800 0.050
MEDTECS INTERNATIONAL CORP 54,941,124 3,000,000 $2,850,142 $0.950 3,000,000 0.550
OUE 90,061,166 2,103,100 $2,445,414 $1.163 21,812,000 2.422
SINGAPORE TECHNOLOGIES ENGINEERING 62,429,441 545,000 $2,115,460 $3.882 7,950,000 0.255
GLOBAL INVESTMENTS 161,476,125 13,036,000 $1,905,182 $0.146 76,014,600 4.708
SILVERLAKE AXIS 257,790,683 7,651,800 $1,901,416 $0.248 12,424,300 0.480
CSE GLOBAL 25,557,371 2,653,900 $1,371,122 $0.517 2,653,900 0.520
AVARGA 94,704,634 3,032,000 $967,417 $0.319 19,271,800 2.035
STAMFORD LAND CORPORATION 78,296,238 905,900 $320,937 $0.354 1,033,600 0.132
BOUSTEAD PROJECTS 31,131,934 291,600 $291,849 $1.001 291,600 0.090
FOOD EMPIRE HOLDINGS 53,597,249 279,200 $255,183 $0.914 3,762,800 0.702
MDR 89,039,757 2,570,100 $201,219 $0.078 5,947,100 0.668
HC SURGICAL SPECIALISTS 15,104,573 176,900 $76,146 $0.430 2,010,700 1.330
TREK 2000 INTERNATIONAL 31,945,342 673,800 $72,462 $0.108 4,610,400 1.440
ECOWISE HOLDINGS 95,034,572 1,500,000 $52,223 $0.035 1,500,000 0.158
MIYOSHI 59,996,089 1,300,000 $45,983 $0.035 3,650,000 0.608
NORDIC GROUP 39,019,100 171,100 $42,378 $0.248 1,905,100 0.490
GRP 18,045,801 241,000 $36,255 $0.150 241,000 0.134
GLOBAL PALM RESOURCES HOLDINGS 19,589,830 224,700 $32,509 $0.145 264,000 0.135
TUAN SING HOLDINGS 118,414,021 60,000 $19,588 $0.326 1,488,400 0.126
CHOO CHIANG HOLDINGS 20,800,000 70,000 $16,869 $0.241 197,600 0.095
LY CORPORATION 48,914,420 65,400 $12,330 $0.189 310,400 0.063
SHOPPER360 11,166,880 89,000 $9,933 $0.112 2,865,200 2.570
Total 58,018,600 $71,812,844

Source: SGX (Data as of 31 March 2021)



Share buyback transactions involve share issuers repurchasing some of their outstanding shares from shareholders through the open market. Once the shares are bought back, they can be converted into treasury shares, which means they are no longer categorised as shares outstanding. Motivations for share buybacks can include employee compensation plans (such as share option schemes or employee share purchase plans) or long term capital management. Buybacks can pick up amidst market declines that are driven by broader moves on international macroeconomic developments.

Share buyback information can be found on the company disclosure page on the SGX website, using the Announcement category and sub-category of Share Buy Back-On Market. As best practice, companies should refrain from buying back their shares during the two weeks immediately before semi-annual financial statements and one month immediately before the full-year financial statements.







This article is provided by SGX My Gateway.



SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the SGX Group Companies) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.












Stock / REIT Search

Advertisement

Advertisement